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The complete loss of mechanical stimuli of skeletal muscles, i.e., the loss of external
strain, related to weight bearing, and internal strain, related to the contraction of
muscle cells, is uniquely observed in pharmacologically paralyzed or deeply sedated
mechanically ventilated intensive care unit (ICU) patients. The preferential loss of myosin
and myosin associated proteins in limb and trunk muscles is a significant characteristic of
critical illness myopathy (CIM) which separates CIM from other types of acquired muscle
weaknesses in ICU patients. Mechanical silencing is an important factor triggering CIM.
Microgravity or ground based microgravity models form the basis of research on the
effect of muscle unloading-reloading, but the mechanisms and effects may differ from the
ICU conditions. In order to understand how mechanical tension regulates muscle mass,
it is critical to know how muscles sense mechanical information and convert stimulus
to intracellular biochemical actions and changes in gene expression, a process called
cellular mechanotransduction. In adult skeletal muscles and muscle fibers, this process
may differ, the same stimulus can cause divergent response and the same fiber type may
undergo opposite changes in different muscles. Skeletal muscle contains multiple types
of mechano-sensors and numerous structures that can be affected differently and hence
respond differently in distinct muscles.
Keywords: critical illness myopathy, mechanical silencing, mechanotransduction, sarcomere, mitochondria,
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INTRODUCTION
The complete loss of mechanical stimuli in skeletal muscles, i.e., the loss of external strain, related to
weight bearing, and internal strain, related to the contraction of muscle cells, is uniquely observed
in pharmacologically paralyzed or deeply sedated mechanically ventilated intensive care unit (ICU)
patients. This mechanical silencing is an important factor triggering the specific critical illness
myopathy (CIM; Ochala et al., 2011a; Llano-Diez et al., 2012; Renaud et al., 2013). Acquired muscle
weaknesses in the ICU is a major complication that occurs in severely ill patients and has significant
impact on the immune system, amino acid reserves, and temperature regulation (Puthucheary
et al., 2010). Muscle wasting and weakness in the ICU is increasingly being recognized and the
increasing prevalence of diagnosed ICU acquired weakness is both due to a growing awareness and
improved survival of patients with prolonged organ failure (Puthucheary et al., 2010). For these
reasons, a thorough understanding of the molecular mechanisms that regulate skeletal muscle mass
is important for development of effective rehabilitation programs and possible pharmacological
interventions that can prevent or alleviate the loss of skeletal muscle mass and function (Isaacson
and Brotto, 2014).
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CIM affects limb and trunk skeletal muscles resulting in
quadriplegia due to a preferential myosin loss, muscle atrophy,
reduced muscle membrane excitability, and unbalanced muscle
metabolism (MacFarlane and Rosenthal, 1977; Rich et al.,
1997, 1998a,b; Larsson et al., 2000; Sander et al., 2002). As
a consequence, the illness often complicates weaning from
the ventilator and increases the length of the stay in the
ICU. This results in prolonged immobility, need for intensive
rehabilitation and increased risk for pneumonia, morbidity,
mortality, and negative economic consequences for health
careproviders. Muscle atrophy occurs within 10–21 days of
muscle disuse when healthy older adults are bound to bedrest.
Similar adverse skeletal muscle changes happen as early as day
5 to 7 after ICU admission in critically ill patients (Puthucheary
et al., 2010).
Many triggering factors have been suggested for CIM
and muscle wasting in the ICU including sepsis, systemic
inflammatory response syndrome (SIRS) and multiple organ
failure. Animal models have, however, allowed the separation
of sepsis and other confounding risk factors, e.g., mechanical
ventilation and muscle unloading, which are usually present
in ICU patients (Banduseela et al., 2009; Ochala et al.,
2011b; Aare et al., 2013). Sepsis on its own has not been
able to replicate the CIM phenotype (Friedrich et al., 2015).
Other potential triggering factors evolve from the interventions
used in modern anesthesiology and in the ICU, that is;
prolonged mechanical ventilation, neuromuscular blockers
(NMB), systemic corticosteroid hormone treatment, and muscle
unloading (Larsson, 2007).
Although themuscle impairment associated with CIM is being
described with increasing accuracy as a result of advances in
genetic and proteomic science, the exact cause and underlying
mechanisms of the disease remain unknown. The loss of skeletal
muscle mass is a complex process that occurs as a consequence
of a variety of stressors. Atrophy includes the reduction of
muscle fiber cross sectional area (CSA) due to a net loss of
proteins, organelles and cytoplasm. This occurs as a result
of alterations in the balance between anabolic and catabolic
processes, with the net result being a loss of muscle mass
when protein breakdown exceeds protein synthesis (Bodine and
Baehr, 2014). Acute muscle atrophy occurs in many pathological
conditions, including neural inactivity, mechanical unloading,
inflammation, metabolic stress, and elevated glucocorticoids
levels. Acute muscle atrophy is then due to hyper-activation
of the main cellular degradation pathways like the ubiquitin-
proteasome system (UPS) and autophagy lysosome pathways
(Sandri, 2013; Schiaffino et al., 2013). However, it is also well
established that muscle unloading induces a rapid decrease in
protein synthesis which contributes to the loss of muscle mass
(Thomason and Booth, 1990; Han et al., 2007).
MUSCLE UNLOADING AND CELLULAR
MECHANOTRANSDUCTION
In order to understand how mechanical tension regulates muscle
mass, it is critical to know how muscles sense mechanical
information and convert stimulus to intracellular biochemical
actions and changes in gene expression, a process called cellular
mechanotransduction (Goldberg, 1968; Goldberg et al., 1975;
Vandenburgh, 1987; Ingber et al., 2014). Skeletal muscle contains
multiple types of mechano-sensors with diverse responses to
changes in tension (Gautel, 2011a). Structures involved in
mechanotransduction include integrins, sarcolemmal structure
proteins, caveolae, cytoskeletal proteins, mitochondria, and
sarcomeric proteins spanning from the Z-disc in to the M-line
in the center of the sarcomere (Figure 1).
Mechanotransduction Pathways
Integrins are a large family of cell surface receptors that links
the extra cellular matrix (ECM) to the cytoskeleton, regulating
many cellular functions including cell proliferation, migration,
and differentiation (Ingber, 1991; Giancotti and Ruoslahti,
1999). Integrins work both as mechanotransducers and adhesive
receptors that can signal trough the cell membrane in both
directions. ECM proteins can bind to integrin receptors and
then form a cluster at the level of the cell membrane. The
cytoplasmic tail of integrins can further associate with various
intracellular proteins which then physically link the integrins
to the internal cytoskeleton. The anchorage complex of ECM
proteins, integrins, and cytoskeletal proteins is known as focal
adhesion that ranges from one side of the cell membrane to the
other (Wary et al., 1996; Giancotti and Ruoslahti, 1999;Wei et al.,
1999; Graham et al., 2015). By forming focal adhesions, integrins
allow mechanical forces to be transmitted to membrane proteins.
Integrins also interact with mechano sensitive ion channels in
focal adhesions (Martinac, 2014).
Caveolae are 60–80 nm cup-shaped invaginations of plasma
membrane formed by caveolins. They are present in many
cells but are particularly abundant in muscle cells, adipocytes,
and endothelial cells. Sinha and colleges established that cells
respond to an acute mechanical stress through rapid flattening
of caveolae into the plasma membrane (Sinha et al., 2011).
Stress-induced flattening of caveolae is strictly passive whereas
the formation of invaginated caveolae is energetically favored
through interactions with cortical actin in the presence of
ATP. The caveolae invaginations are supported by extracellular
matrix (ECM), which serves as external support, and the
cytoskeleton, whose contraction and expansion locally regulate
the mechanosensitivity of mechanosensitive channels in animal
and human cells.
Wang and co-workers, were able to demonstrate that
mitochondria also play an essential role in mechanotransduction.
By confocal microscopy they confirmed that mitochondria
associate directly with microtubules and distribute throughout
the entire cytoplasm (Wang et al., 2001). In addition
to microtubules, other cytoskeletal proteins, such as the
intermediate filament desmin, are connected to mitochondria
to provide a coordinated movement and alignment throughout
the depth of the cell (Rappaport et al., 1998; Milner et al.,
2000). When a mechanical pulling stress is applied to integrins,
mitochondria show movement near the surface of the nucleus.
These results demonstrate that the strains transported across
integrins to microfilaments are passed via load-bearing
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FIGURE 1 | Mechanosensing in skeletal muscle. Different pathways involved in mechanosensing and tensegrity in skeletal muscle are briefly summarized. Multiple
signaling pathways influence protein synthesis and degradation in the muscle fiber spanning from the muscle membrane and extracellular matrix to the M-band in the
center of the sarcomere. IGF-1 has been suggested to play an important role for the muscle hypertrophy induced by mechanical overload. In addition caveolae,
respond to cell stress and stretch-induced signaling, and many different proteins involved in cell signaling bind to caveolins, such as neural nitric oxide synthase
(nNOS), tyrosine kinases, small GTPases, and growth receptors. Integrins spanning from the extacellular matrix to the interior of the muscle cell, linked to cytoskeletal
actin, directly connect to the nuclei and mitochondria, thus allowing a “hard-wired” and rapid signal propagation to nuclear and mitochondrial DNA. A number of
sarcomeric proteins are involved in mechanosensing, and there is emerging evidence of a very dynamic exchange of multiple sarcomeric proteins to the cytoplasmic
pool affecting muscle gene expression in response to mechanical load from the Z-line to the center of the sarcomere in the M-band. Multiple major signaling cascades
are downstream effectors of mechanosensing, such as PI-3K, MAPKs, calmodulin, calcineurin, glycogen synthase kinase, AMP activated kinase, and Akt/mTOR.
interconnections to microtubules on which the mitochondria
anchor, indicating the essential role of mitochondria in
mechano-sensing.
The cytoskeleton is the core molecular structure of an active
cell and actin microfilaments, microtubules, and intermediate
filaments comprise the three major filamentous components of
this structure. These filaments link to themselves, to form larger
fibrils, and to each other to form structurally coupled networks
(Ingber et al., 2014). The fundamental idea of cellular tensegrity
is that the cytoskeleton is stabilized by an elastic prestress
that is generated and maintained through a complementary
force balance between contractile actomyosin filaments and by
intracellular structures, such as microtubules, and extracellular
binding sites to the extracellular matrix and to other cells (Ingber
et al., 1981, 1985; Ingber, 1993, 1997, 2003, 2006). Actin is
also the major protein component of the thin filaments in the
sarcomere and when myosin, the motor protein binds to actin,
substantial mechanical stress is generated on various structures
of the sarcomere (Gautel, 2011b). The sarcomeres in striated
muscle represent the basic molecular unit for the contractile
force. Actin in the thin filaments are crosslinked at the Z-
disc, whereas the thick filaments, mainly composed of myosin,
are attached to the M-band of the sarcomere that can deliver
cross stabilization. The distance between the myosin and actin
cross-links, at the M-band and Z-disc, is determined by the
giant sarcomeric scaffold titin (aka. connectin). In addition to
their mechanical function, these sub-sarcomeric structures and
their molecular components are greatly involved in cellular
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mechanotransduction (Hoshijima, 2006; Linke, 2008). The
sarcomeric Z-disc, as well as the M-band, has increasingly been
recognized as hubs for signaling pathways that mediate diverse
intracellular processes including cell growth and differentiation,
as well as protein turnover and gene expression (Hoshijima, 2006;
Durieux et al., 2007).
Via the sarcomeric protein telethonin located in the Z-disc,
the Z-disc cross talks to growth factors. Further, it has also
been shown that telethonin interacts with several other proteins
outside the Z-disk and relocalizes in response to stress or atrophy
signals (Gautel, 2008). The sarcomeric M-band has also been
shown to play a critical role in mechanotransduction and an
M-band signaling complex, consisting of titin, Nbr1, p62, and
MURF2 mediate gene expression and muscle protein turnover
in response to biomechanical stress via the nuclear translocation
of the transcription factor serum response factor (SRF) (Lange
et al., 2005; Peng et al., 2005; Will et al., 2010). Another
member of the M-band proteins, Myosin-interacting M-band-
associated stress-responsive protein (myosap, aka. leucine rich
repeat containing 39 protein, LRRC39) binds to the myosin
tail domain. Will and co-workers demonstrated that myosin is
involved in mechanically activated gene transcription via SRF
in cardiomyocytes (Will et al., 2010). This indicates that the M-
band may contain several mechanostransducers that can control
gene expression (Gautel, 2008). Additionally, titin has a kinase
domain that is linked to the control of muscle gene expression
and protein turnover, located at the M-band of the sarcomere
(Lange et al., 2005). Titin was long considered a simple molecular
spring, controlling the resting length of sarcomeres. However, it
has been established that titin is involved in mechanical signaling
pathways in heart muscle (Krüger and Linke, 2009) and several
ubiquitin-linked signaling proteins are targeted to, and around
the protein kinase domain of titin (Witt et al., 2005; Gautel, 2008).
Preferential Myosin Loss in Muscle
Unloading Associated with CIM
To date, most studies on the effects of muscle unloading have
focused on the effects of removing the external load induced
by weight bearing in response to hind limb suspension or
microgravity. In immobilized ICU patients, in addition to the
removal of the external load by weight bearing, the internal
strain in response to activation of contractile proteins is also
missing. This results in the complete mechanical silencing,
unique for mechanically ventilated, and deeply sedated or
pharmacologically paralyzed ICU patients. Microgravity or
ground based microgravity models form the basis of research on
the effect of muscle unloading-reloading, but the mechanisms
and effects may differ from the ICU conditions. The preferential
loss of myosin and myosin associated proteins in limb and
trunk muscles is a significant characteristic of CIM which
separates CIM from other types of acquired muscle weaknesses
in ICU patients (Larsson et al., 2000). This phenotype is
reproduced in a unique experimental rat ICU model, used in our
research group, allowing long-term mechanical ventilation in a
deeply sedated, extensively monitored, and pharmacologically
paralyzed rats by post synaptic neuromuscular blockade
(Norman et al., 2006; Larsson, 2007). This model is not
limited by the early mortality (within 1–3 days) observed
when commercially available ventilators are used and the
longest duration a rat has been continuously monitored and
mechanically ventilated to date is 3 months (Dworkin and
Dworkin, 1990). In this experimental model, the complete
mechanical silencing for long durations, typically longer than
1 week, results in a similar geno- and phenotype as in ICU
patients with CIM, i.e., a preferential loss of myosin and
myosin associated proteins in parallel with a transcriptional
down-regulation of contractile proteins and activation of
protein degradation pathways in a typical temporal pattern
in limb and trunk muscles (Norman et al., 2006; Ochala
et al., 2011a). In accordance with the tensegrity model, mild
passive mechanical loading reduces the preferential myosin
loss seen in both fast- and slow-twitch muscles as well as the
loss of specific force at the single muscle fiber level (Renaud
et al., 2013). Similar findings were also observed in response
to passive loading in deeply sedated and immobilized ICU
patients (Llano-Diez et al., 2012). The significant muscle
sparing effect in response to loading is mediated via multiple
mechanosensing pathways involving protein degradation
pathways and mitochondria resulting in decreased protein
degradation, reduced oxidative stress and improved function of
mitochondria.
PROTEIN SYNTHESIS IN MUSCLE
UNLOADING
Removing the pre-stress generated by the complementary force
balance, i.e., muscle unloading, induces a rapid decrease in
protein synthesis which contributes to the loss of muscle mass
(Thomason and Booth, 1990; Han et al., 2007). The primary effect
of mechanical stimulation on protein synthesis appears to occur
at the level of translational efficiency (Goldspink, 1977; Kimball
et al., 2002) and components of the mammalian/mechanistic
target of rapamycin (mTOR) play a critical role in the mechanical
regulation of protein synthesis and skeletal muscle mass
(Thomason and Booth, 1990; Jackman and Kandarian, 2004;
Han et al., 2007; Hornberger, 2011). However, different types
of mechanical loading/unloading regulates protein synthesis and
muscle mass in a distinct manner (Isaacson and Brotto, 2014).
Initially mTOR was identified as a cytoplasmic protein
associated with intracellular membranes in early non-muscle
studies (Withers et al., 1997; Sabatini et al., 1999) and
subsequently shown to associate with the endoplasmic reticulum
(ER) and Golgi apparatus in different cell lines (Drenan et al.,
2004). Additionally mTOR has been found to be associated with
the outer mitochondrial membrane, suggesting a potential role
in the regulation of energy metabolism and also demonstrating
the involvement ofmTOR in the process ofmechanotransduction
(Desai et al., 2002; Isaacson and Brotto, 2014).
mTOR occurs in two complexes; mTOR complex 1 (mTORC1)
and mTOR complex 2 (mTORC2). mTORC1 is the rapamycin
sensitive complex that consist of the regulatory associated
protein of mTOR (RAPTOR), mammalian lethal with SEC13
protein 8 (mLST8; a.k.a. GbL), the Dep domain-containing
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mTOR-interacting protein (DEPTOR) and the proline-rich Akt
substrate of 40 kDa (PRAS40). In contrast, mTORC2 is the
rapamycin-insensitive complex, composed of the rapamycin
insensitive companion of mTOR (RICTOR), mLST8, DEPTOR,
stress-activated protein kinase-interacting protein 1 (mSIN1) and
the protein observed with RICTOR (PROTOR; Weigl, 2012).
Several studies have shown that mTORC1 signaling regulates
initiation of translation through the phosphorylation of
substrates such as eukaryotic initiation factor (eIF), 4E binding
protein-1 (4EBP-1), ribosomal protein S6 (S6), and p70
ribosomal protein S6 kinase (S6K) (Heitman et al., 1991;
Haghighat et al., 1995; Hara et al., 1997; Baar and Esser, 1999).
These substrates are key regulators of protein synthesis, and are
expressed in all cell types (Weigl, 2012). The efficiency of an
mRNA is mainly controlled by the eukaryotic initiation factor
4E (eIF4E) which is also part of the eIF4F-complex, together
with eIF4G and eIF4A. eIF4A is an RNA helicase which is
able to unwind hairpin structures in the 5′untranslated region
(UTR) of mRNAs, hence promoting the translational process
(Ray et al., 1983; Rogers et al., 2001). 4E-BP1 is an inhibitory
phospho-protein, that in the hypo-phosphorylated state, is
bound to eIF4E and thereby hindering the association of the
eIF4F-complex. When mTORC1 phosphorylates 4EBP-1, 4EBP-
1 detaches from eIF4E, increases the formation of the eIF4F
complex and improves protein synthesis rate (Weigl, 2012).
S6K1 is a positive regulator of protein translation initiation.
mTORC1 phosphorylates S6K which in turn phosphorylates
several other proteins affecting translation initiation like S6 and
eIF4B, another member of the initiation eIF4F-complex (Holz
et al., 2005). Thus, the control of translation initiation by mTOR
is a key regulator of protein synthesis in skeletal muscle (You
et al., 2015).
The upstream regulators of mTORC1 are linked with growth
factors, nutrients, energy and stress. Growth factors like insulin
and insulin growth factor (IGF) stimulate phosphoinositide
3 kinase (PI3K), which leads to the activation of Akt (aka.
protein kinase B, PKB). Activated Akt phosphorylates the
tuberous sclerosis complex 2 (TSC2) which is a protein that
forms the TSC1/2 complex, together with TSC1 (Inoki et al.,
2002). Phosphorylation of TSC2, by Akt, prevent its inhibition
of Rheb from promoting mTORC1 activity (Stocker et al.,
2003; Weigl, 2012). In addition to Akt, mTORC1 responds
to many upstream signals, including amino acids. Further,
mTORC1 controls several cellular processes in addition to
protein synthesis such as autophagy (Sandri, 2010). Rapamycin
inhibits mechanically induced growth and mechanically induced
changes in protein synthesis in skeletal muscles (Kubica et al.,
2005; Hornberger et al., 2007), this together with studies using
transgenic mice models of mTORC1 inactivation indicate that
mechanical stimulation of skeletal muscles is sufficient to activate
mTORC1, and that the activation of mTORC1 is the basis for the
increased protein synthesis and muscle growth observed under
mechanical stimulation (Weigl, 2012).
Application of a static stretch to skeletal muscle myotubes
in vitro significantly increases amino acid transport into stretched
cells (Vandenburgh and Kaufman, 1982) which may also activate
mTORC1 in an Akt independent manner. Whether the increase
in amino acid transport that results from mechanical activation
of voltage-sensitive sodium channels contribute significantly to
muscle growth or metabolism remains to be tested (Tidball,
2005).
MUSCLE DEGRADATION IN MUSCLE
UNLOADING
Activation of proteolytic systems in cells is regulated at the
gene level and the transcripts associated with muscle atrophy
have been studied by gene expression profiling (Bodine et al.,
2001; Gomes et al., 2001). A subset of genes that are commonly
up- or down- regulated in muscle atrophy, irrespective of
the underlying cause, have been identified and referred to as
atrophy-related genes or “atrogenes” (Bodine et al., 2001; Gomes
et al., 2001; Lecker et al., 2004; Sacheck et al., 2007). Among
these atrogenes there are several transcripts associated with
the ubiquitin proteasome system (UPS) and autophagy (Sandri,
2008).
Atrogenes and protein degradation are blocked by the
activation of Akt. Akt phosphorylates Forkhead Box (Fox) O,
thus inhibiting the UPS. Members of the FoxO family (FoxO1, 3,
and 4), downstreamAkt, have been identified as key transcription
factors controlling the expression of MuRF1 and atrogin-1.
Additionally it has been shown that FoxO3, specifically, also
regulates autophagy (Sandri et al., 2004; Mammucari et al.,
2007; Zhao et al., 2007). Recent work by Milan et al. (2015)
demonstrates that muscle-specific deletion of FoxO members
protects the muscle from atrophy, further demonstrating the role
of FoxOs in the induction of the UPS and the autophagy lysosome
pathway. Furthermore, it was demonstrated that FoxOs control
several stress-response pathways such as the unfolded protein
response, ROS detoxification, DNA repair and translation (Milan
et al., 2015).
Ubiquitin Proteasome System
The UPS is an ATP-dependent proteolytic system that targets
proteins with ubiquitin (Ub) molecule substrates, through a
cascade of conjugating enzymes (ligases), for identification
of degradation (Murton et al., 2008). The ubiquitin ligase
enzymes (E3) bind the protein substrate and once a protein is
ubiquitinated, it is unfolded and fed into the proteasome in an
ATP-dependent process (Sandri, 2013). Two important atrogenes
that have been found in several animal models of muscle
atrophy including unloading are muscle-specific E3s; atrogin-
1 and muscle RING finger-1 (MuRF1; Kisselev and Goldberg,
2001). These two atrogenes have been extensively studied in
muscle protein degradation and their involvement in muscle
atrophy is well known. Mice lacking atrogin-1 and MuRF1 are
resistant to muscle atrophy in response to denervation and
knockdown of atrogin-1 prevents muscle wasting induced by
fasting (Bodine et al., 2001; Cong et al., 2011).
It has been shown that MuRF1 interacts with and controls
the half-life of several essential muscle structural proteins like
troponin I (Kedar et al., 2004), MyHC (Clarke et al., 2007; Fielitz
et al., 2007), and actin (Polge et al., 2011). So far only a few
muscle proteins have been identified as substrates for atrogin-1.
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The substrates found are however all related to growth-associated
processes (Tintignac et al., 2005; Csibi et al., 2010).
Further, MuRF1 and atrogin-1 are also upregulated in limb
muscles, in response to complete mechanical silencing and the
upregulation of these E3 ligases precedes both themuscle atrophy
and the preferential myosin loss in response to mechanical
silencing (Ochala et al., 2011a; Renaud et al., 2013). In addition,
a similar temporal up-regulation pattern of these two atrogenes
is also observed in the diaphragm muscle in the experimental
rat ICU model, used in our lab, but in the absence of the
preferential myosin loss. Even though MuRF1 and atrogin-1 are
significant Ub-ligases involved in muscle atrophy, there are likely
to be other E3s related to muscle wasting in response to muscle
mechanical silencing. Further, the preferential myosin loss in
response to the ICU condition cannot be solely explained by
the activation of these atrogenes. Particular Ub ligases can be
involved in different muscle atrophy models and in different
stages of the process. Recently a new set of Ub ligases have been
discovered as significant atrogenes that are under the control
of the FoxO-family. This set of Ub-ligases includes MUSA1,
an E3, that has been found to be critical in muscle atrophy
during denervation and fasting (Sartori et al., 2013), Fbxo31,
an additional E3, Itch, a Ub-ligase that regulates the half-life of
several transcription factors, and Fbxo21, a gene of unknown
function but that contains an F-boxmotif and that has been given
the name SMART (Specific of muscle atrophy and regulated by
transcription). This novel set of E3s were all up-regulated in
response to denervation induced atrophy (Milan et al., 2015).
Autophagy Lysosome Pathway
Autophagy is recognized as a crucial protein degradation
mechanism in muscle in addition to the ubiquitin–proteasome
system (Sandri, 2008), but is also emerging as a novel mechanism
in regulating cellular signal transduction by removing activated
signaling proteins (Gautel, 2008; Backues and Klionsky, 2011).
Autophagy is a physiological process that is vital for the cells to
eliminate damaged cell-components and to remodel the cellular
architecture (Neel et al., 2013). There are three types of autophagy
that all promote proteolytic degradation of cytosolic components;
macro-autophagy, micro-autophagy, and chaperone mediated
autophagy (CMA). Both macro- and micro-autophagy can
ingest large structures through selective and non-selective
mechanisms. Macro-autophagy transports cytoplasmic cargo to
the lysosome through the intermediate of an autophagosome,
a double membrane-bound vesicle. The autophagosome then
fuses with the lysosome forming an autolysosome. In contrast,
in micro-autophagy, the cytosolic components are taken up by
the lysosome directly through invagination of the lysosomal
membrane (Glick et al., 2010; Sandri, 2010). In the third type
of CMA, proteins that have been targeted are translocated in a
complex with chaperone proteins (such as heat shock proteins),
and can cross the lysosomal membrane. This way the targeted
proteins are recognized by the lysosomal membrane receptor,
lysosomal-associated membrane protein 2A (LAMP-2A), and are
subsequently unfolded and degraded (Saftig et al., 2008).
Autophagy is primarily considered to be a non-selective
degradation pathway, but autophagy can trigger the selective
elimination of specific organelles, such as mitochondria (via
mitophagy). Parkin, PINK1, Bnip3, and Bnip3L are genes
that have been identified in mammals to control mitophagy,
inactivation of the genes encoding these proteins lead to
abnormal mitochondria (Hara et al., 2006). During muscle
wasting the mitochondrial network is drastically remodeled in
response to fasting or denervation, and autophagy plays an
important part in this process (Romanello et al., 2010; Romanello
and Sandri, 2010). Alteration in mitochondrial dynamics is
sufficient to cause muscle wasting in mice, indicating that
disturbance of the mitochondrial network is essential for the
muscle homeostasis (Romanello et al., 2010; Romanello and
Sandri, 2010).
MUSCLE SPECIFIC DIFFERENCES
Skeletal muscles are heterogeneous at the whole muscle, motor
unit and individual muscle fiber levels. The different muscle
properties decide the optimal function of eachmuscle, motor unit
and muscle fiber. An important aspect of muscle diversity lies
in their embryological origin (Sambasivan et al., 2009; Merrell
and Kardon, 2013). Craniofacial muscles, are evolutionarily and
developmentally distinct from trunk and limb muscles (Noden
and Francis-West, 2006; Sambasivan et al., 2011). Trunk and limb
muscles are derived from somites that originate from the paraxial
mesoderm of the trunk, whereas the cranial mesoderm gives
rise to head muscles like extraocular muscles and cheek muscles
like the masseter and the buccinators (Grifone and Kelly, 2007;
Nathan et al., 2008; Harel et al., 2009). MyoD, Myf5 and Mrf4
are myogenic regulatory factors that work together to control
the entry to the myogenic differentiation program that applies
to all skeletal muscles. However, the regulatory hierarchies that
act upstream of the myogenic factors are diverse in somatic
and cranial mesoderm (Czajkowski et al., 2014). Significant
differences between muscles also lies in further development into
mature skeletal muscles (Merrell and Kardon, 2013).
In adult skeletal muscles and muscle fibers, the same stimulus
can cause divergent responses. The same fiber type may undergo
opposite changes in different muscles. Even within the same
muscle different fiber types react differently (Blaauw et al.,
2013; Schiaffino et al., 2013). The nervous system utilizes the
capacity of the muscles to generate force and movement for
a variety of motor tasks. These tasks can roughly be divided
into three main types; postural joint stabilization, long lasting
repetitive activities (like respiration), and fast and powerful
actions (such as jumping or kicking). In mammals the motor
units are functionally organized into separate components, the
motor units each consist of a motoneuron and the muscle fibers
that it exclusively innervates. Muscle fibers attain a degree of
specialized molecular structure and physiological parameters to
perfectly suit the needs of the motor units (Blaauw et al., 2013).
The heterogeneity of skeletal muscle fibers, therefore, mainly
reflects an adaptation to the different patterns of activity; in
addition it also indicates specialization in membrane properties,
calcium shuttling mechanisms, contractile machinery, and the
structure of the cytoskeleton (Polla et al., 2004; Schiaffino and
Reggiani, 2011).
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The diaphragm is a muscle engaged in continuous rhythmic
activity and diaphragm muscle fibers are characterized by fatigue
resistance (Polla et al., 2004; Merrell and Kardon, 2013). In
addition to ventilation, the diaphragm muscle is also required
for coughing, talking and singing, activities which are phasic
and occasional. Diaphragm fibers generally have a smaller CSA
than limb muscles. However, the number of capillary vessels
surrounding each fiber is the same, the diffusion distance is
reduced which makes the oxygen supply more efficient in the
diaphragm than in other muscles. This might improve oxygen
diffusion and contribute to the increased resistance of the
diaphragm to fatigue. Respiratory muscle fibers do not undergo
the same changes in response to training and inactivity as limb
muscle fibers (Polla et al., 2004; Merrell and Kardon, 2013).
The diaphragm muscle is severely affected in many ICU
patients exposed to mechanical ventilation resulting in the rapid
development of diaphragmatic weakness due to both atrophy and
contractile dysfunction. This harmful effect of prolonged MV
has been named ventilator-induced diaphragmatic dysfunction
(VIDD; Vassilakopoulos and Petrof, 2004; Powers et al., 2013).
Approximately 25% of mechanically ventilated ICU patients
experience difficult weaning (Daniel Martin et al., 2013) and the
weaning procedures account for 40–60% of the total time on
the ventilator (Esteban et al., 1994, 1995). This has significant
negative consequences for patient quality of life with an increased
risk for pneumonia, mortalaity, and morbidity as well as
profound economic consequences for health care providers.
In spite of lack of a preferential myosin loss in the
diaphragm, diaphragm muscle fiber function, i.e., fiber atrophy
and maximum force normalized to muscle fiber cross-sectional
area (specific force), was decreased by more than 85% after 10
days mechanical ventilation in the experimental rat ICU model
(Corpeno et al., 2014). An early and maintained oxidative stress
in response to controlled mechanical ventilation seems to be a
key factor triggering post-translational protein modifications of
the myosinmolecule, impairedmyofibrillar protein organization,
and fiber atrophy (Corpeno et al., 2014). The temporal pattern,
the phenotype, and mechanism underlying the loss of contractile
proteins differ between the diaphragm and limb muscles in
response to mechanical ventilation and may in part be related
to the passive mechanical loading of the diaphragm by the
ventilator, but is most probably also a consequence of other
known and unknown factors such as muscle specific differences,
oxidative stress, protein modifications and the release of specific
factors from the respiratory system (Corpeno et al., 2014).
CONCLUSION
The uniquely observed mechanical silencing seen in
pharmacologically paralyzed or deeply sedated mechanically
ventilated ICU patients is an important factor triggering
the specific CIM. Passive mechanical loading significantly
alleviates these effects indicating the important role of cellular
mechanotransduction in skeletal muscles. There is a growing
body of evidence showing that mitochondrial activity plays
an important role in the regulation of muscle size and there
is emerging evidence demonstrating the important role of
mitochondria in mechano signaling in skeletal muscle. The
mechanisms controlling the effects of mechanosensation are
part of an intricate biological system with important muscle
specific differences that needs to be taken into account when
designing strategies for reducing muscle wasting and weakness
in immobilized and mechanically ventilated ICU patients.
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